Alcon Stock Rated Buy by BTIG Following TRYPTYR Approval
On May 30, BTIG analysts reaffirmed their Buy rating and $99 price target for Alcon Inc. (NYSE:ALC) following the FDA's approval of TRYPTYR for the treatment of dry eye disease (DED).
Alcon Inc (ALC)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Select Equity Group Robert Joseph Caruso | 5,478,428 | $515,303,507 | -16% | 2.22% |
| 2. | Rudius Management Murat Ozbaydar | 2,024,768 | $192,211,226 | +3% | 39.49% |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,531,776 | $144,350,890 | -63% | 0.18% |
| 4. | Cantillon Capital Management William Von Mueffling | 1,464,533 | $139,028,118 | 0.9% | |
| 5. | Antipodes Partners Jacob Mitchell | 1,195,712 | $112,478,248 | +5% | 3.52% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 20,080,296 | $1,905,318,886 | 0.03% | |
| 2. | 17,164,650 | $1,619,578,956 | 0.1% | |
| 3. | 1,333,526 | $1,262,869,950 | 1.77% | |
| 4. | 12,221,766 | $1,159,404,242 | 2.31% | |
| 5. | 11,726,307 | $1,113,178,324 | 0.29% |
News See All
Alcon Inc. (ALC)’s TRYPTYR Wins FDA Nod for Dry Eye Disease
Alcon Inc. (NYSE:ALC) has announced that the U.S.
Alcon Inc. (NYSE:ALC) Q1 2025 Earnings Call Transcript
Operator: Greetings, and welcome to the Alcon First Quarter 2025 Earnings Call. At this time, all participants are in a listen-only mode.
Here’s Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC)
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Alcon Inc. (NYSE:ALC) Q4 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the Alcon Fourth Quarter and 2024 Earnings Call. At this time, all participants are in a listen-only mode.
Alcon Inc. (ALC): A Bull Case Theory
We came across a bullish thesis on Alcon Inc. (ALC) on Substack by Kontra Investment Xchange. In this article, we will summarize the bulls’ thesis on ALC. Alcon Inc.
Alcon Inc. (NYSE:ALC) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Alcon third quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode.
UBS' Top Tech Based Disruptive Stocks For 2030: Top 29 Stocks
When it comes to investing and making massive gains on the stock market, disruption is the name of the game. The biggest firms on the market right now are all disruptors of their industries.
Oppenheimer's Favorite Stocks For Next 12 Months: Top 32 Stock Picks
The tail end of August is appearing to turn a fresh page for Wall Street.
Alcon Inc. (NYSE:ALC) Q2 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Alcon Second Quarter 2024 Earnings Call. At this time, all participants are in a listen-only mode.